ClinConnect ClinConnect Logo
Search / Trial NCT04080440

Brain-injured Patients Extubation Readiness Study

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Sep 4, 2019

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Coma Intensive Care Units Critical Care Stroke Traumatic Brain Injury Anoxic Ischemic Encephalopathy Glasgow Coma Scale

ClinConnect Summary

The Brain-injured Patients Extubation Readiness Study, or BIPER, is a clinical trial designed to help critically-ill patients with brain injuries who need to be taken off mechanical ventilation, which is a machine that helps them breathe. The study looks at using a simple scoring system to determine if these patients are ready to have their breathing tube removed, aiming to reduce the chances of complications after extubation, or the process of removing the tube.

To be eligible for this study, participants should be between 18 and 75 years old and have a recent brain injury that requires them to be in the intensive care unit (ICU) on a ventilator for more than 48 hours. They should also show some signs of stability, like being able to breathe on their own during certain tests. If someone meets these criteria and chooses to participate, they can expect to be part of a process that may help improve care for future patients with similar conditions. It's important to know that not everyone will qualify, as there are specific health conditions that could exclude them from the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Acute cerebral lesion with a Glasgow Coma Scale \< 13 needing admission in ICU and mechanical ventilation with tracheal intubation for neurological cause : cerebrovascular stroke either ischemic or hemorrhagic including aneurysmal subarachnoid hemorrhage, traumatic brain injury or anoxo ischemic encephalopathy after cardiac arrest
  • Mechanical ventilation more than 48 hours
  • 18 to 75 years old
  • Neurological stability with no intracranial hypertension with minimal sedation
  • Glasgow Coma Scale motor response \< 6
  • Spontaneous breathing trial succeeded
  • First extubation attempt
  • Exclusion Criteria:
  • Posterior cranial fossa lesion
  • Admission for status epilepticus or central nervous system infection
  • Spinal cord injury (tetraplegia or paraplegia)
  • Uncontrolled status epilepticus or uncontrolled central nervous system infection
  • Life expectancy less than 48 hours or withdrawal of life sustaining therapy
  • Chronic respiratory failure
  • More than 3 failed spontaneous breathing trials
  • Chest trauma (more than 2 broken ribs / broken sternum / with an indication of open thoracic surgery)
  • Surgery planned within 7 days
  • Tracheotomy
  • Previous compromised upper airway permeability
  • Pregnant or breastfeeding woman
  • Adult under the protection of the law or without social assurance system
  • Inclusion in another clinical study about ventilation weaning

About University Hospital, Clermont Ferrand

The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.

Locations

Angers, , France

Bordeaux, , France

Grenoble, , France

Toulouse, , France

Lille, , France

Clermont Ferrand, , France

Poitiers, , France

Lyon, , France

Nîmes, , France

Montpellier, , France

Valence, , France

Saint Etienne, , France

Caen, , France

Rennes, , France

Paris, , France

Nantes, , France

Marseille, , France

Bourg En Bresse, , France

Nice, , France

La Réunion, , France

Patients applied

0 patients applied

Trial Officials

Russell Chabanne

Study Director

University Hospital, Clermont-Ferrand

Olivier Vincent

Principal Investigator

University Hospital, Grenoble

Florent Gobert

Principal Investigator

Hospices Civils de Lyon

Jérôme Morel

Principal Investigator

CHU SAINT-ETIENNE

Matthieu Jeannot

Principal Investigator

CH VALENCE

Pierre-André Rodié-Talbère

Principal Investigator

Nantes University Hospital

Thomas Geeraerts

Principal Investigator

CHU Toulouse

Pierre-François Perrigault

Principal Investigator

University Hospital, Montpellier

Claire Roger

Principal Investigator

CHU Nîmes

Carole Ichai

Principal Investigator

CHU NICE

Mohamed Khemili

Principal Investigator

Fondation Ophtalmologique Adolphe de Rothschild

Camille Bouisse

Principal Investigator

CH de Bourg-en-Bresse

Natalie De Sa

Principal Investigator

CHU Lille

Sigismond Lasocki

Principal Investigator

University Hospital, Angers

Claire Dahyot-Fizelier

Principal Investigator

CHU Poitiers

Yoann Launey

Principal Investigator

CHU Rennes

Laurent Petit

Principal Investigator

CHU Bordeaux - Réanimation Chirurgicale et traumatologique

Hugues De Courson

Principal Investigator

CHU Bordeaux - Réanimation Neurologique

Clément Gakuba

Principal Investigator

CHU Caen Normandie

Sophie Kauffmann

Principal Investigator

CHU de La Réunion

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials